Page last updated: 2024-09-05

phosphatidylcholines and transforming growth factor beta

phosphatidylcholines has been researched along with transforming growth factor beta in 12 studies

Compound Research Comparison

Studies
(phosphatidylcholines)
Trials
(phosphatidylcholines)
Recent Studies (post-2010)
(phosphatidylcholines)
Studies
(transforming growth factor beta)
Trials
(transforming growth factor beta)
Recent Studies (post-2010) (transforming growth factor beta)
32,2044435,59349,11956017,610

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's5 (41.67)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berra, E; Cornet, ME; Diaz-Meco, MT; Dominguez, I; Garcia de Herreros, A; Johansen, T; Moscat, J; Municio, MM; Sanz, L1
Doyle, CA; Kellogg, CK; Nielsen, HC1
Cronstein, BN; Gold, LI; Haines, KA; Kolasinski, SL; Reibman, J; Weissmann, G1
Halstead, J; Ignotz, RA; Kemp, K1
Guarner, F; Malagelada, JR; Mourelle, M1
Honeyman, T; Ignotz, RA1
Chai, MQ; Chen, HH; Chen, JS; Liang, J; Song, JG; Zhao, S; Zhou, BH1
Cao, Q; Lieber, CS; Mak, KM2
Bezouglaia, O; Demer, LL; Huang, MS; Lu, J; Morony, S; Tetradis, S; Tintut, Y; Tseng, W; Zhang, Z1
Ali, N; Banerjee, A; De, M1
Admasu, TD; Batchu, KC; Cazenave-Gassiot, A; Gruber, J; Ng, LF; Wenk, MR1

Other Studies

12 other study(ies) available for phosphatidylcholines and transforming growth factor beta

ArticleYear
Phospholipase C-mediated hydrolysis of phosphatidylcholine is a target of transforming growth factor beta 1 inhibitory signals.
    Molecular and cellular biology, 1992, Volume: 12, Issue:1

    Topics: Animals; Bacillus cereus; Cell Line; Enzyme Activation; Genes, myc; Hydrolysis; Insulin; Keratinocytes; Kinetics; Mice; Microinjections; Oocytes; Phosphatidylcholines; Progesterone; Protamine Kinase; Proto-Oncogene Proteins p21(ras); Transforming Growth Factor beta; Type C Phospholipases; Xenopus laevis

1992
Development of fibroblast-type-II cell communications in fetal rabbit lung organ culture.
    Biochimica et biophysica acta, 1992, Dec-15, Volume: 1175, Issue:1

    Topics: Animals; Cell Communication; Dihydrotestosterone; Fetus; Fibroblast Growth Factors; Glucocorticoids; Lung; Models, Biological; Organ Culture Techniques; Phosphatidylcholines; Pulmonary Surfactants; Rabbits; Transforming Growth Factor beta

1992
Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling.
    Journal of immunology (Baltimore, Md. : 1950), 1993, Aug-01, Volume: 151, Issue:3

    Topics: Adult; Chemotaxis, Leukocyte; Enzyme Activation; GTP Phosphohydrolases; GTP-Binding Proteins; Humans; In Vitro Techniques; Membrane Lipids; Neutrophils; Pertussis Toxin; Phosphatidylcholines; Phosphatidylinositols; Phospholipase D; Receptors, Cell Surface; Receptors, Neurokinin-1; Receptors, Neurotransmitter; Receptors, Transforming Growth Factor beta; Second Messenger Systems; Signal Transduction; Substance P; Transforming Growth Factor beta; Type C Phospholipases; Virulence Factors, Bordetella

1993
Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-beta signaling.
    The Journal of biological chemistry, 1995, Jun-09, Volume: 270, Issue:23

    Topics: Alkaloids; Bridged-Ring Compounds; GTP-Binding Proteins; Humans; Norbornanes; Phosphatidylcholines; Plasminogen Activator Inhibitor 1; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Thiocarbamates; Thiones; Transforming Growth Factor beta; Tumor Cells, Cultured; Type C Phospholipases

1995
Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis.
    Gastroenterology, 1996, Volume: 110, Issue:4

    Topics: Analysis of Variance; Animals; Chronic Disease; Colitis; Collagen; Collagenases; Colon; Colonic Diseases; Constriction, Pathologic; Dietary Fats, Unsaturated; Disease Models, Animal; Intestinal Obstruction; Male; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid

1996
TGF-beta signaling in A549 lung carcinoma cells: lipid second messengers.
    Journal of cellular biochemistry, 2000, Jun-12, Volume: 78, Issue:4

    Topics: Acetophenones; Arachidonic Acid; Bridged-Ring Compounds; Calcium; Chelating Agents; Chromatography, Thin Layer; Diglycerides; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Extracellular Matrix; Humans; Hydrolysis; Lipids; Lung Neoplasms; Norbornanes; Phosphatidylcholines; Phosphodiesterase Inhibitors; Plasmids; Protein Isoforms; Second Messenger Systems; Sphingosine; Thiocarbamates; Thiones; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured; Type C Phospholipases

2000
Activation of phospholipase D activity in transforming growth factor-beta-induced cell growth inhibition.
    Cell research, 2000, Volume: 10, Issue:2

    Topics: Animals; Cell Division; Cell Line; Diglycerides; Dogs; Enzyme Activation; Growth Inhibitors; Humans; Mink; Phosphatidylcholines; Phosphatidylinositol Phosphates; Phospholipase D; Transforming Growth Factor beta; Transforming Growth Factor beta1

2000
Dilinoleoylphosphatidylcholine prevents transforming growth factor-beta1-mediated collagen accumulation in cultured rat hepatic stellate cells.
    The Journal of laboratory and clinical medicine, 2002, Volume: 139, Issue:4

    Topics: Actins; Animals; Cells, Cultured; Collagen Type I; Collagenases; Desmin; Fluorescent Antibody Technique; Gene Expression; Hepatocytes; Male; Matrix Metalloproteinase 13; Phosphatidylcholines; Procollagen; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vimentin

2002
DLPC decreases TGF-beta1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2002, Volume: 283, Issue:5

    Topics: Animals; Catalase; Collagen; Collagen Type I; Enzyme Inhibitors; Hydrogen Peroxide; Imidazoles; Liver; Male; Mitogen-Activated Protein Kinases; Osmolar Concentration; Oxidants; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphatidylcholines; Phosphorylation; Procollagen; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1

2002
Atherogenic phospholipids attenuate osteogenic signaling by BMP-2 and parathyroid hormone in osteoblasts.
    The Journal of biological chemistry, 2007, Jul-20, Volume: 282, Issue:29

    Topics: Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Mice; Nuclear Receptor Subfamily 4, Group A, Member 2; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Parathyroid Hormone; Phosphatidylcholines; Phospholipids; Phosphorylcholine; Signal Transduction; Transcription Factors; Transforming Growth Factor beta

2007
Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Amines; Animals; Anti-Bacterial Agents; Cells, Cultured; Cricetinae; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunity, Humoral; Immunologic Factors; Interleukin-10; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Paromomycin; Phosphatidylcholines; Transforming Growth Factor beta

2011
Lipid profiling of C. elegans strains administered pro-longevity drugs and drug combinations.
    Scientific data, 2018, 10-23, Volume: 5

    Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Caloric Restriction; Drug Combinations; Lipid Metabolism; Longevity; Phosphatidylcholines; Phosphatidylethanolamines; Receptors, Nicotinic; Transcription Factors; Transforming Growth Factor beta; Triglycerides

2018